US 6545034
Use of etodolac for the treatment of chronic lymphocytic leukemia
expired A61KA61K31/198A61K31/407
Quick answer
US patent 6545034 (Use of etodolac for the treatment of chronic lymphocytic leukemia) held by The Regents of the University of California expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/198, A61K31/407, A61K45/06